Arrowhead Pharmaceuticals, Inc.(ARWR)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ARWR | 8.58 B | - | 171.00% | -47.79% | -$2.25 | -55.21% | 2.96x | 0.00% | $95.49 | $34.61 |
SMMT | 13.70 B | - | - | 0.00% | -$1.11 | -192.51% | 3.24x | 0.00% | $29.23 | $12.07 |
MDGL | 11.02 B | - | 71.20% | -25.32% | -$13.89 | -53.31% | 0.66x | 0.00% | $615.00 | $393.61 |
BMRN | 10.63 B | 148.35x | 19.90% | 2.14% | $0.37 | 1.18% | 0.66x | 0.00% | $70.98 | $49.26 |
IONS | 7.20 B | - | -40.70% | -64.66% | -$3.43 | -105.50% | 4.98x | 0.00% | $86.74 | $43.01 |
Peer Valuation & Performance Analysis
Peer group analysis for Arrowhead Pharmaceuticals, Inc. (ARWR) compared to its primary competitors (including SMMT, MDGL, BMRN) reveals distinct metrics. ARWR trades at a valuation discount relative to its competitors, with a P/E ratio of -27.0x versus the peer average of 21.5x (representing a 226% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, ARWR's revenue growth of 171.0% exceeds the peer average of 16.8%, highlighting its competitive strength and market share gains. Additionally, its net margin of -47.8% is below the peer average of -22.0%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ARWR ranks #0 in P/E ratio, #1 in revenue growth, and #4 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $60.54 | $61.13 | $59.20 | $60.74 | 1,784,700 | -1.20% |
| 2026-10-07 | $61.63 | $62.75 | $60.78 | $61.48 | 1,819,200 | -0.10% |
| 2026-10-06 | $62.86 | $63.19 | $60.56 | $61.54 | 1,675,500 | -1.30% |
| 2026-10-05 | $64.76 | $64.76 | $62.22 | $62.35 | 2,249,400 | -2.87% |
| 2026-10-02 | $65.57 | $66.16 | $63.99 | $64.19 | 1,487,600 | -0.93% |
| 2026-10-01 | $65.00 | $65.75 | $64.50 | $64.79 | 1,521,700 | -1.01% |
| 2026-09-30 | $66.80 | $66.80 | $65.09 | $65.45 | 1,742,700 | -1.21% |
| 2026-09-29 | $65.46 | $66.83 | $64.57 | $66.25 | 2,869,600 | +1.21% |
| 2026-09-28 | $65.00 | $66.11 | $63.99 | $65.46 | 1,589,700 | -0.70% |
| 2026-09-25 | $66.50 | $67.44 | $65.40 | $65.92 | 1,616,200 | -0.23% |
| 2026-09-24 | $67.00 | $67.45 | $65.46 | $66.07 | 1,626,300 | -1.33% |
| 2026-09-23 | $72.16 | $72.49 | $66.27 | $66.96 | 2,554,500 | -6.82% |
| 2026-09-22 | $68.85 | $72.36 | $68.08 | $71.86 | 3,115,700 | +4.46% |
| 2026-09-21 | $67.45 | $69.26 | $66.06 | $68.79 | 2,347,400 | +3.47% |
| 2026-09-18 | $67.83 | $68.05 | $66.36 | $66.48 | 4,016,000 | -1.86% |
Explore More Analysis for ARWR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.